Advertisement
UK markets close in 1 hour 58 minutes
  • FTSE 100

    8,053.79
    +13.41 (+0.17%)
     
  • FTSE 250

    19,616.44
    -102.93 (-0.52%)
     
  • AIM

    753.38
    -1.31 (-0.17%)
     
  • GBP/EUR

    1.1663
    +0.0018 (+0.15%)
     
  • GBP/USD

    1.2464
    +0.0002 (+0.01%)
     
  • Bitcoin GBP

    50,676.29
    -2,308.24 (-4.36%)
     
  • CMC Crypto 200

    1,345.16
    -37.41 (-2.70%)
     
  • S&P 500

    5,003.70
    -67.93 (-1.34%)
     
  • DOW

    38,011.88
    -449.04 (-1.17%)
     
  • CRUDE OIL

    82.77
    -0.04 (-0.05%)
     
  • GOLD FUTURES

    2,328.60
    -9.80 (-0.42%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,868.39
    -220.31 (-1.22%)
     
  • CAC 40

    7,975.01
    -116.85 (-1.44%)
     

Company News For Jan 18, 2018

Tilly's (TLYS) closed the most recent trading day at $16.18, moving -0.98% from the previous trading session.
  • Tiffany & Co’s TIF shares rose 1.3% after reporting that its global comparable sales advanced 5% in the last two months of 2017

  • Shares of CSX Corporation CSX decreased 0.8% after posting fourth quarter revenues of $2,863 million, missing the Zacks Consensus Estimate of $2,882.2 million

  • Juno Therapeutics, Inc’s JUNO shares jumped 51.9% on news that Celgene Corporation CELG is looking to acquire the biotech company

  • Shares of Fastenal Company FAST slumped 5.8% after its fourth quarter operating profit margin declined 0.57% year-over-year to 18.7%


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CSX Corporation (CSX) : Free Stock Analysis Report
 
Fastenal Company (FAST) : Free Stock Analysis Report
 
Celgene Corporation (CELG) : Free Stock Analysis Report
 
Juno Therapeutics, Inc. (JUNO) : Free Stock Analysis Report
 
Tiffany & Co. (TIF) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research